Clinical Trial Update: Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache [Phase 2]

View source ↗

Summary

Phase 2 dose-ranging study evaluating the efficacy and tolerability of tonabersat for migraine prophylaxis; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine Without Aura
• Migraine with Aura

Drugs mentioned

• Tonabersat (tonabersat)

Snippet

Sponsor: Minster Research Ltd | Conditions: Migraine Without Aura, Migraine With Aura | Phase 2 | Status: COMPLETED